Cargando…
Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand
BACKGROUND: New Zealand initiated HPV vaccination in 2008, and has attained 3-dose coverage of ~50 % in 12–13 year old girls. Due to the success of program initiatives in Māori girls, higher coverage rates of ~60 % have been achieved in this group. We have previously reported a benchmark overall pre...
Autores principales: | Kang, Yoon-Jung, Lewis, Hazel, Smith, Megan A., Simonella, Leonardo, Neal, Harold, Bromhead, Collette, Canfell, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546322/ https://www.ncbi.nlm.nih.gov/pubmed/26297490 http://dx.doi.org/10.1186/s12879-015-1034-5 |
Ejemplares similares
-
Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand
por: Simonella, Leonardo M, et al.
Publicado: (2013) -
Non-Māori-speaking New Zealanders have a Māori proto-lexicon
por: Oh, Y., et al.
Publicado: (2020) -
A cohort study comparing cardiovascular risk factors in rural Māori, urban Māori and non-Māori communities in New Zealand
por: Cameron, Vicky A, et al.
Publicado: (2012) -
Disparities in Cancer-Specific Survival Between Māori and Non-Māori New Zealanders, 2007-2016
por: Gurney, Jason, et al.
Publicado: (2020) -
Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study
por: Bromhead, Collette, et al.
Publicado: (2021)